Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: A proteomic signature validated by enzyme-linked immunosorbent assay

Liver Transplantation

Volumn 17, Issue 6, 2011, Pages 723-732

  Massoud, Omar ^a   Heimbach, Julie ^b   Viker, Kimberly ^b   Krishnan, Anuradha ^b   Poterucha, John ^b   Sanchez, William ^b   Watt, Kymberly ^b   Wiesner, Russell ^b   Charlton, Michael ^b  

^a University of Alabama at Birmingham   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FIBRINOGEN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; SERUM AMYLOID A;

ACUTE GRAFT REJECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; LIQUID CHROMATOGRAPHY; LIVER GRAFT; MALE; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BIOPSY; COMPLEMENT C4; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HEPATITIS C; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION;

EID: 79957712545     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22266     Document Type: Article

References (69)

1. Adam R, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 1231-1243. (Pubitemid 37536793)
2. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L,. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004; 10: 886-897. (Pubitemid 38979259)
3. Lee KW, Cameron AM, Maley WR, Segev DL, Montgomery RA,. Factors affecting graft survival after adult/child split-liver transplantation: analysis of the UNOS/OPTN data base. Am J Transplant 2008; 8: 1186-1196. (Pubitemid 351763667)
4. Wiesner RH, Demetris AJ, Belle S, Seaberg EC, Lake JR, Zetterman RK, et al. Acute hepatic allograft rejection: incidence, risk factors and impact on outcome. Hepatology 1998; 28: 638-645. (Pubitemid 28405409)
5. Charlton M, Seaberg E,. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl Surg 1999; 5 (4 Suppl 1): S107-S114. (Pubitemid 29321242)
6. Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, et al. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant 2009; 9: 301-308.
7. Klintmalm GB, Washburn WK, Rudich SM, Heffron TG, Teperman LW, Fasola C, et al. Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study. Liver Transpl 2007; 13: 1521-1531. (Pubitemid 350168192)
8. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology 2000; 31: 792-799. (Pubitemid 30118655)
9. Regev A, Molina E, Moura R, Bejarano PA, Khaled A, Ruiz P, et al. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl 2004; 10: 1233-1239. (Pubitemid 39406076)
10. Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S,. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 2005; 19: 110-114. (Pubitemid 40227861)
11. Thuluvath PJ, Krok KL,. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol 2006; 101: 1497-1499. (Pubitemid 43980622)
12. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ,. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525. (Pubitemid 16138427)
13. Bjorhall K, Miliotis T, Davidsson P,. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005; 5: 307-317. (Pubitemid 40189661)
14. Washburn MP, Wolters D, Yates JR III,. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001; 19: 242-247. (Pubitemid 32220565)
15. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572-577. (Pubitemid 34178440)
16. Jacobs JM, Adkins JN, Qian WJ, Liu T, Shen Y, Camp DG II, Smith RD,. Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res 2005; 4: 1073-1085. (Pubitemid 41208665)
17. DeSouza L, Diehl G, Rodrigues MJ, Guo J, Romaschin AD, Colgan TJ, Siu KW,. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 2005; 4: 377-386. (Pubitemid 40548142)
18. DeSouza L, Diehl G, Yang EC, Guo J, Rodrigues MJ, Romaschin AD, et al. Proteomic analysis of the proliferative and secretory phases of the human endometrium: protein identification and differential protein expression. Proteomics 2005; 5: 270-281. (Pubitemid 40189657)
19. O'Riordan E, Orlova TN, Mei JJ, Butt K, Chander PM, Rahman S, et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 2004; 15: 3240-3248. (Pubitemid 39578857)
20. Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP,. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003; 237: 660-664.
21. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004; 15: 219-227. (Pubitemid 38020714)
22. Schaub S, Wilkins JA, Antonovici M, Krokhin O, Weiler T, Rush D, Nickerson P,. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 2005; 5 (4 pt 1): 729-738. (Pubitemid 40461282)
23. Borozdenkova S, Westbrook JA, Patel V, Wait R, Bolad I, Burke MM, et al. Use of proteomics to discover novel markers of cardiac allograft rejection. J Proteome Res 2004; 3: 282-288. (Pubitemid 38500996)
24. Martin SE, Shabanowitz J, Hunt DF, Marto JA,. Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem 2000; 72: 4266-4274.
25. Belov ME, Gorshkov MV, Udseth HR, Anderson GA, Smith RD,. Zeptomole-sensitivity electrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry of proteins. Anal Chem 2000; 72: 2271-2279. (Pubitemid 30322291)
26. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R,. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999; 17: 994-999. (Pubitemid 29474856)
27. Chong PK, Gan CS, Pham TK, Wright PC,. Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: implication of multiple injections. J Proteome Res 2006; 5: 1232-1240. (Pubitemid 43727802)
28. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 2006; 5: 1143-1154. (Pubitemid 43727792)
29. Simpson MA, Madras PN, Monaco AP,. Immunologic heterogeneity among potential transplant recipients. Prospects for predicting immune responses to allografts with in vitro tests. Clin Lab Med 1991; 11: 733-762.
30. Toyoda M, Galfayan K, Wachs K, Czer L, Jordan SC,. Immunologic monitoring of OKT3 induction therapy in cardiac allograft recipients. Clin Transplant 1995; 9: 472-480.
31. Deng MC, Erren M, Kammerling L, Gunther F, Kerber S, Fahrenkamp A, et al. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 1995; 60: 1118-1124.
32. Kimball PM, Radovancevic B, Isom T, Spickard A, Frazier OH,. The paradox of cytokine monitoring-predictor of immunologic activity as well as immunologic silence following cardiac transplantation. Transplantation 1996; 61: 909-915. (Pubitemid 26107427)
33. Wu CJ, Kurbegov D, Lattin B, Burchard E, Finkle C, Valantine H, et al. Cytokine gene expression in human cardiac allograft recipients. Transpl Immunol 1994; 2: 199-207. (Pubitemid 24278720)
34. Satoh S, Thomson AW, Nakamura K, Warty V, Todo S,. Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver, and small bowel-plus-liver transplant recipients. Transplantation 1995; 60: 558-562.
35. Venkatesh N, Feng Y, DeDecker B, Yacono P, Golan D, Mitchison T, McKeon F,. Chemical genetics to identify NFAT inhibitors: potential of targeting calcium mobilization in immunosuppression. Proc Natl Acad Sci U S A 2004; 101: 8969-8974. (Pubitemid 38781595)
36. Murphy LL, Hughes CC,. Endothelial cells stimulate T cell NFAT nuclear translocation in the presence of cyclosporin A: involvement of the wnt/glycogen synthase kinase-3 beta pathway. J Immunol 2002; 169: 3717-3725.
37. Granja C, Moliterno RA, Ferreira MS, Fonseca JA, Kalil J, Coelho V,. T-cell autoreactivity to Hsp in human transplantation may involve both proinflammatory and regulatory functions. Hum Immunol 2004; 65: 124-134. (Pubitemid 38224138)
38. Birk OS, Gur SL, Elias D, Margalit R, Mor F, Carmi P, et al. The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci U S A 1999; 96: 5159-5163. (Pubitemid 29214552)
39. Lakkis FG,. Transplant rejection: mind your T-cell language. Nat Med 2002; 8: 1043-1044. (Pubitemid 35175938)
40. Pratt JR, Basheer SA, Sacks SH,. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582-587. (Pubitemid 34633435)
41. Marsh JE, Farmer CK, Jurcevic S, Wang Y, Carroll MC, Sacks SH,. The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 2001; 72: 1310-1318. (Pubitemid 33026614)
42. Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF,. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk Res 1984; 8: 521-534. (Pubitemid 14051256)
43. Andrews RG, Torok-Storb B, Bernstein ID,. Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies. Blood 1983; 62: 124-132. (Pubitemid 13070601)
44. Nakamura Y, Noma M, Kidokoro M, Kobayashi N, Takei M, Kurashima S, et al. Expression of CD33 antigen on normal human activated T lymphocytes. Blood 1994; 83: 1442-1443. (Pubitemid 24062870)
45. Thomas R, Davis LS, Lipsky PE,. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J Immunol 1993; 151: 6840-6852. (Pubitemid 24001059)
46. Handgretinger R, Schafer HJ, Baur F, Frank D, Ottenlinger C, Buhring HJ, Niethammer D,. Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells. Immunol Lett 1993; 37: 223-228. (Pubitemid 23303738)
47. Davey FR, Mick R, Nelson DA, MacCallum J, Sobol RE, Royston I, et al. Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen. Leukemia 1988; 2: 420-426.
48. Raptis A, Clave E, Mavroudis D, Molldrem J, Van Rhee F, Barrett AJ,. Polymorphism in CD33 and CD34 genes: a source of minor histocompatibility antigens on haemopoietic progenitor cells? Br J Haematol 1998; 102: 1354-1358. (Pubitemid 28435226)
49. Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Dijke PT, Chantry A,. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene 2005; 24: 8080-8084. (Pubitemid 41746751)
50. Tanaka T, Soriano MA, Grusby MJ,. SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity 2005; 22: 729-736. (Pubitemid 40814503)
51. Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC, Karin M,. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 2004; 306: 271-275. (Pubitemid 39336871)
52. Rajendra R, Malegaonkar D, Pungaliya P, Marshall H, Rasheed Z, Brownell J, et al. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J Biol Chem 2004; 279: 36440-36444. (Pubitemid 39128984)
53. Chen ZY, Wang X, Zhou Y, Offner G, Tseng CC,. Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res 2005; 65: 10394-10400. (Pubitemid 41743733)
54. Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T,. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene 1996; 12: 1789-1801. (Pubitemid 26146304)
55. Gilks CB, Bear SE, Grimes HL, Tsichlis PN,. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol 1993; 13: 1759-1768. (Pubitemid 23068114)
56. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A,. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991; 65: 737-752. (Pubitemid 121001306)
57. Schreiber SL,. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991; 251: 283-287. (Pubitemid 21916873)
58. Patterson CE, Abrams WR, Wolter NE, Rosenbloom J, Davis EC,. Developmental regulation and coordinate reexpression of FKBP65 with extracellular matrix proteins after lung injury suggest a specialized function for this endoplasmic reticulum immunophilin. Cell Stress Chaperones 2005; 10: 285-295. (Pubitemid 41813377)
59. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J,. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001; 294: 1942-1945. (Pubitemid 33101594)
60. Sarbassov DD, Ali SM, Sabatini DM,. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005; 17: 596-603. (Pubitemid 41540408)
61. Feucht HE, Felber E, Gokel MJ, Hillebrand G, Nattermann U, Brockmeyer C, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991; 86: 464-470.
62. Crespo M, Pascual M, Tolkoff-Rubin N, Mauiyyedi S, Collins AB, Fitzpatrick D, et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652-658. (Pubitemid 32268068)
63. Crespo M, Lozano M, Sole M, Mila J, Esforzado N, Martorell J, Oppenheimer F,. Diagnosis and treatment of acute humoral rejection after kidney transplantation: preliminary experience. Transplant Proc 2003; 35: 1677-1678. (Pubitemid 37093670)
64. Krukemeyer MG, Moeller J, Morawietz L, Rudolph B, Neumann U, Theruvath T, et al. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation 2004; 78: 65-70.
65. Lorho R, Turlin B, Aqodad N, Triki N, de Lajarte-Thirouard AS, Camus C, et al. C4d: a marker for hepatic transplant rejection. Transplant Proc 2006; 38: 2333-2334. (Pubitemid 46068533)
66. Bu X, Zheng Z, Wang C, Yu Y,. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells. Pathol Res Pract 2007; 203: 163-167.
67. Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, et al. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant 2006; 20: 624-633. (Pubitemid 44383409)
68. Lee KC, Chang CY, Chuang YC, Sue SH, Chu TW, Chen RJ, et al. Measurement of human erythrocyte C4d to erythrocyte complement receptor 1 ratio in cardiac transplant recipients with acute symptomatic allograft failure. Transplant Proc 2008; 40: 2638-2642.
69. Sanchez-Soriano RM, Almenar L, Martinez-Dolz L, Reganon E, Martinez-Sales V, Chamorro CI, et al. Diagnostic usefulness of inflammatory markers in acute cellular rejection after heart transplantation. Transplant Proc 2006; 38: 2569-2571. (Pubitemid 44693745)